Temporal determination of lung NO system and COX-2 upregulation following ischemia–reperfusion injury

REFERENCES

• den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL: Lung ischemia–reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol. 2010;299:H1283–H1299.
   PubMed Web of Science ®Google Scholar
• Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND: Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med. 2009;179:220–227.
   PubMed Web of Science ®Google Scholar
• Hickey MJ, Granger DN, Kubes P: Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol Scand. 2001;173:119–126.
   PubMedGoogle Scholar
• Kaminski A, Pohl CB, Sponholz C, Ma N, Stamm C, Vollmar B, Steinhoff G: Up-regulation of endothelial nitric oxide synthase inhibits pulmonary leukocyte migration following lung ischemia–reperfusion in mice. Am J Pathol. 2004;164:2241–2249.
   PubMed Web of Science ®Google Scholar
• Cobelens PM, van Putte BP, Kavelaars A, Heijnen CJ, Kesecioglu J: Inflammatory consequences of lung ischemia–reperfusion injury and low-pressure ventilation. J Surg Res. 2009;153:295–301.
   PubMed Web of Science ®Google Scholar
• Hickey MJ, Sharkey KA, Sihota EG, Reinhardt PH, Macmicking JD, Nathan C, Kubes P: Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia. FASEB J. 1997;11:955–964.
   PubMed Web of Science ®Google Scholar
• Ovechkin AV, Lominadze D, Sedoris KC, Robinson TW, Tyagi SC, Roberts AM: Lung ischemia–reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch Physiol Biochem. 2007;113:1–12.
   PubMedGoogle Scholar
• Ovechkin AV, Lominadze D, Sedoris KC, Gozal E, Robinson TW, Roberts AM: Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia–reperfusion in rabbits. J Appl Physiol. 2005;99:2423–2432.
   PubMed Web of Science ®Google Scholar
• Roberts AM, Ovechkin AV, Mowbray JG, Robinson TW, Lominadze D: Effects of pulmonary ischemia–reperfusion on platelet adhesion in subpleural arterioles in rabbits. Microvasc Res. 2004;67:29–37.
   PubMed Web of Science ®Google Scholar
• Parviz M, Bousamra M, 2nd, Chammas JH, Birks EK, Presberg KW, Jacobs ER, Nelin LD: Effects of chronic pulmonary overcirculation on pulmonary vasomotor tone. Ann Thorac Surg. 1999;67:522–527.
   PubMed Web of Science ®Google Scholar
• Robertson BE, Warren JB, Nye PC: Inhibition of nitric oxide synthesis potentiates hypoxic vasoconstriction in isolated rat lungs. Exp Physiol. 1990;75:255–257.
   PubMed Web of Science ®Google Scholar
• Adnot S, Raffestin B, Eddahibi S: NO in the lung. Respir Physiol. 1995;101:109–120.
   PubMedGoogle Scholar
• Poon BY, Raharjo E, Patel KD, Tavener S, Kubes P: Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity. Circulation. 2003;108:1107–1112.
   PubMed Web of Science ®Google Scholar
• Droge W: Free radicals in the physiological control of cell function. Physiol Rev. 2002;82:47–95.
   PubMed Web of Science ®Google Scholar
• Bolli R, Shinmura K, Tang XL, Kodani E, Xuan YT, Guo Y, Dawn B: Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc Res. 2002;55:506–519.
   PubMed Web of Science ®Google Scholar
• Kodani E, Xuan YT, Shinmura K, Takano H, Tang XL, Bolli R: Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits. Am J Physiol Heart Circ Physiol. 2002;283:H1943–H1957.
   PubMed Web of Science ®Google Scholar
• Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, Bolli R: Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA. 2000;97:10197–10202.
   PubMed Web of Science ®Google Scholar
• Hide EJ, Ney P, Piper J, Thiemermann C, Vane JR: Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels. Br J Pharmacol. 1995;116:2435–2440.
   PubMed Web of Science ®Google Scholar
• Jugdutt BI, Hutchins GM, Bulkley BH, Becker LC: Dissimilar effects of prostacyclin, prostaglandin E1, and prostaglandin E2 on myocardial infarct size after coronary occlusion in conscious dogs. Circ Res. 1981;49:685–700.
   PubMed Web of Science ®Google Scholar
• Shinmura K, Nagai M, Tamaki K, Tani M, Bolli R: COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts. Am J Physiol Heart Circ Physiol. 2002;283:H2534–H2543.
   PubMed Web of Science ®Google Scholar
• Thiemermann C, Zacharowski K: Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins. Pharmacol Ther. 2000;87:61–67.
   PubMed Web of Science ®Google Scholar
• Xiao CY, Hara A, Yuhki K, Fujino T, Ma H, Okada Y, Takahata O, Yamada T, Murata T, Narumiya S, Ushikubi F: Roles of prostaglandin I(2) and thromboxane A(2) in cardiac ischemia–reperfusion injury: a study using mice lacking their respective receptors. Circulation. 2001;104:2210–2215.
   PubMed Web of Science ®Google Scholar
• Sedoris KC, Gozal E, Ovechkin AV, Theile AR, Roberts AM: Interplay of endothelial and inducible nitric oxide synthases modulates the vascular response to ischaemia-reperfusion in the rabbit lung. Acta Physiol (Oxf). 2012 Mar;204: 331–343.
   Google Scholar
• Matute-Bello G, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2008;295:L379–L399.
   PubMed Web of Science ®Google Scholar
• Shaul PW, North AJ, Brannon TS, Ujiie K, Wells LB, Nisen PA, Lowenstein CJ, Snyder SH, Star RA: Prolonged in vivo hypoxia enhances nitric oxide synthase type I and type III gene expression in adult rat lung. Am J Respir Cell Mol Biol. 1995 Aug;13:167–174.
   PubMed Web of Science ®Google Scholar
• Sherman TS, Chen Z, Yuhanna IS, Lau KS, Margraf LR, Shaul PW. Nitric oxide synthase isoform expression in the developing lung epithelium. Am J Physiol. 1999;276(2 Pt 1):L383–L390.
   PubMed Web of Science ®Google Scholar
• Asano K, Chee CB, Gaston B, Lilly CM, Gerard C, Drazen JM, Stamler JS: Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci USA. 1994;91:10089–10093.
   PubMed Web of Science ®Google Scholar
• Michel T, Feron O: Nitric oxide synthases: which, where, how, and why? J Clin Invest. 1997;100:2146–2152.
   PubMed Web of Science ®Google Scholar
• Numata M, Suzuki S, Miyazawa N, Miyashita A, Nagashima Y, Inoue S, Kaneko T, Okubo T: Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J Immunol. 1998;160:3031–3037.
   PubMed Web of Science ®Google Scholar
• LaPointe MC, Isenovic E: Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension. 1999;33(1 Pt 2):276–282.
   PubMed Web of Science ®Google Scholar
• Corbett JA, Kwon G, Turk J, McDaniel ML: IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry. 1993;32:13767–13770.
   PubMed Web of Science ®Google Scholar
• Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, Iadecola C: Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA. 1998;95:10966–10971.
   PubMed Web of Science ®Google Scholar
• Serou MJ, DeCoster MA, Bazan NG: Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res. 1999;58:593–598.
   PubMed Web of Science ®Google Scholar
• Mgbemena V, Segovia JA, Chang TH, Tsai SY, Cole GT, Hung CY, Bose S: Transactivation of inducible nitric oxide synthase gene by Kruppel-like factor 6 regulates apoptosis during influenza A virus infection. J Immunol. 2012;189: 606–615.
   PubMed Web of Science ®Google Scholar